NCT04644380 is a NA clinical trial of INVOcell in Infertility, sponsored by INVO Bioscience, Inc..

Who is sponsoring NCT04644380?

NCT04644380 is sponsored by INVO Bioscience, Inc..

What drugs are being tested in NCT04644380?

Interventions in NCT04644380: INVOcell.

What condition does NCT04644380 study?

NCT04644380 studies Infertility.

Is NCT04644380 still recruiting?

NCT04644380 is currently completed. Last updated 17 February 2021.

Last reviewed 2021-02-17 · How we verify

NCT04644380

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessment of the INVOcell Culture Device When Used for up to Five-Day Incubation

Completed NA Last updated 17 February 2021

What this trial tests

NA trial testing INVOcell in Infertility in 31 participants. Completed in 11 December 2020.

Timeline

2 December 2020

Primary endpoint
11 December 2020

11 December 2020

Quick facts

Lead sponsor	INVO Bioscience, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	31
Start date	2 December 2020
Primary completion	11 December 2020
Estimated completion	11 December 2020
Sites	1 location across United States

Drugs / interventions tested

INVOcell

Conditions studied

Infertility — all drugs for Infertility →

Sponsor

INVO Bioscience, Inc.

Who can join

Adults 18 to 42, female only, with Infertility. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The INVOcell Culture Device received de novo request for 3-day intravaginal incubation. The device is held in place with the intravaginal cavity by a Retention Device. The clinical study will assess the ability of a modified Retention Device to hold INVOcell in place during 5-day vaginal incubation as well as comfort and vaginal irritation as secondary endpoints.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Infertility

Currently open trials in the same condition.

NCT07074015 — IntelliWell: An AI-Assisted Imaging Platform for Detection and Location of Ultra-Rare Testicular Sperm in Surgical Speci · NA · recruiting
NCT07358468 — Impact Of FET Preparation Protocol On Endometrial Peristalsis: A Prospective Cohort Study · recruiting
NCT07340827 — A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH · Phase 3 · recruiting
NCT07369362 — To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That · NA · active not recruiting
NCT07153367 — Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauter · Phase 2 · recruiting

Other INVO Bioscience, Inc. trials

Trials by the same sponsor.

NCT05189405 — 3 Year Retrospective Analysis of IVF in Comparison With INVOcell · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04644380 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by INVO Bioscience, Inc.
Last refreshed: 17 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04644380.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing